Lastacaft FDA Approval History
FDA Approved: Yes (First approved July 28, 2010)
Brand name: Lastacaft
Generic name: alcaftadine
Dosage form: Ophthalmic Solution
Company: Allergan plc
Treatment for: Conjunctivitis, Allergic
Lastacaft (alcaftadine ophthalmic solution) is a topical H1 histamine receptor antagonist for eye allergy itch relief.
- Lastacaft is available over-the-counter. Lastacaft was originally approved as a prescription medicine, but the FDA approved a complete prescription to over-the-counter (OTC) switch in December 2021.
- Lastacaft is administered into the eyes once-daily to relieve itchy eyes due to pollen, ragweed, grass, animal hair and dander.
Development timeline for Lastacaft
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
